(Q44233614)

1 December 2017

Investigation of extended-spectrum beta-lactamase in Klebsiellae pneumoniae and Escherichia coli from China (English)

1 reference

People's Republic of China

1 December 2017

0 references

1 reference

Zizhong Xiong

1

1 reference

1 December 2017

Demei Zhu

2

1 reference

1 December 2017

Fu Wang

3

1 reference

1 December 2017

Yingyuan Zhang

4

1 reference

1 December 2017

Ryoichi Okamoto

5

1 reference

1 December 2017

Matsuhisa Inoue

6

1 reference

1 December 2017

1 October 2002

1 reference

Diagnostic Microbiology and Infectious Disease

1 December 2017

1 reference

1 December 2017

44

1 reference

1 December 2017

195-200

1 reference

1 December 2017

2

1 reference

What's New in beta-lactamases?

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

TEM- and SHV-derived extended-spectrum beta-lactamases: relationship between selection, structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

Mutants of Escherichia coli that are resistant to certain beta-lactam compounds lack the ompF porin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

Evolution of plasmid-coded resistance to broad-spectrum cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

beta-Lactamases in laboratory and clinical resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

Loss of OmpC porin in a strain of Salmonella typhimurium causes increased resistance to cephalosporins during therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

Extended-spectrum beta-lactamases in Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

Origin and impact of plasmid-mediated extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

A novel chromosomal TEM derivative and alterations in outer membrane proteins together mediate selective ceftazidime resistance in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

Outer membrane protein change combined with co-existing TEM-1 and SHV-1 beta-lactamases lead to false identification of ESBL-producing Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

Presence of genes for beta-lactamases of two different classes on a single plasmid from a clinical isolate of Serratia marcescens

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900441-8

7 January 2021

10.1016/S0732-8893(02)00441-8

Identifiers

DOI

1 reference

1 December 2017

1 reference